GB201608806D0 - Method - Google Patents
MethodInfo
- Publication number
- GB201608806D0 GB201608806D0 GBGB1608806.4A GB201608806A GB201608806D0 GB 201608806 D0 GB201608806 D0 GB 201608806D0 GB 201608806 A GB201608806 A GB 201608806A GB 201608806 D0 GB201608806 D0 GB 201608806D0
- Authority
- GB
- United Kingdom
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/461—Cellular immunotherapy characterised by the cell type used
- A61K39/4614—Monocytes; Macrophages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/462—Cellular immunotherapy characterized by the effect or the function of the cells
- A61K39/4622—Antigen presenting cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
- A61K39/4643—Vertebrate antigens
- A61K39/4644—Cancer antigens
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0645—Macrophages, e.g. Kuepfer cells in the liver; Monocytes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K39/46
- A61K2239/46—Indexing codes associated with cellular immunotherapy of group A61K39/46 characterised by the cancer treated
- A61K2239/52—Intestine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/22—Colony stimulating factors (G-CSF, GM-CSF)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2502/00—Coculture with; Conditioned medium produced by
- C12N2502/50—Coculture with; Conditioned medium produced by invertebrate cells
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1608806.4A GB201608806D0 (en) | 2016-05-19 | 2016-05-19 | Method |
PCT/GB2016/052690 WO2017198979A1 (en) | 2016-05-19 | 2016-08-31 | A method for producing macrophages by incubating monocytes with non-viable mycobacterium |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1608806.4A GB201608806D0 (en) | 2016-05-19 | 2016-05-19 | Method |
Publications (1)
Publication Number | Publication Date |
---|---|
GB201608806D0 true GB201608806D0 (en) | 2016-07-06 |
Family
ID=56369618
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB1608806.4A Ceased GB201608806D0 (en) | 2016-05-19 | 2016-05-19 | Method |
Country Status (2)
Country | Link |
---|---|
GB (1) | GB201608806D0 (en) |
WO (1) | WO2017198979A1 (en) |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE284220T1 (en) * | 1999-02-03 | 2004-12-15 | Idm Immuno Designed Molecules | COMPOSITION CONTAINING MACROPHAGES WITH ANTINIFECTIVE AND HEMATOPOIETIC PROPERTIES AND METHOD OF PRODUCTION THEREOF |
US8647678B2 (en) * | 2009-08-24 | 2014-02-11 | Wisconsin Alumni Research Foundation | Anti-inflammatory macrophages and uses thereof |
WO2014102799A1 (en) * | 2012-12-30 | 2014-07-03 | Carmel-Haifa University Economic Corporation Ltd | CD11blow MACROPHAGES AND CONDITIONED MEDIA THEREOF FOR TREATING CANCER AND/OR FIBROSIS |
GB201308325D0 (en) * | 2013-05-09 | 2013-06-19 | Immodulon Therapeutics Ltd | Cancer Therapy |
-
2016
- 2016-05-19 GB GBGB1608806.4A patent/GB201608806D0/en not_active Ceased
- 2016-08-31 WO PCT/GB2016/052690 patent/WO2017198979A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2017198979A1 (en) | 2017-11-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB201607521D0 (en) | Method | |
GB201609221D0 (en) | Method | |
GB201609220D0 (en) | Method | |
GB201602394D0 (en) | Method | |
GB201601773D0 (en) | Method | |
GB201608918D0 (en) | Method | |
GB201603367D0 (en) | Method | |
GB201608403D0 (en) | Method | |
GB201614884D0 (en) | Method | |
GB201607572D0 (en) | Alyklation method | |
GB201602927D0 (en) | Method | |
GB201601120D0 (en) | Eye-testing method | |
GB201608969D0 (en) | Method | |
GB201608806D0 (en) | Method | |
GB201608848D0 (en) | Method | |
GB201608658D0 (en) | Method | |
GB201608660D0 (en) | Method | |
GB201608469D0 (en) | Method | |
GB201607828D0 (en) | Method | |
GB201607463D0 (en) | Method | |
GB201604898D0 (en) | Method | |
GB201604620D0 (en) | Method | |
GB201604572D0 (en) | Method | |
GB201604291D0 (en) | Method | |
GB201604204D0 (en) | Method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |